December 16th, 2021 | 13:41 CET
Shares with top news: Plug Power, BioNTech, Prospect Ridge
Inflation fears and uncertainty about the impact of the Omicron variant on the course of the Corona pandemic are currently driving stock prices. These are very volatile, with a downward tendency. Highflyers such as Plug Power and BioNTech have also corrected significantly. However, there is positive news about both companies. Plug Power reports further cooperation in the USA to reach the medium-term delivery targets, and BioNTech's vaccine protects against severe disease progression at Omicron. The vaccine is in short supply in Germany. There were several pieces of positive news recently from Prospect Ridge Resources. The gold explorer seems to be sitting on a real treasure.
time to read: 3 minutes
|
Author:
Fabian Lorenz
ISIN:
PLUG POWER INC. DL-_01 | US72919P2020 , BIONTECH SE SPON. ADRS 1 | US09075V1026 , Prospect Ridge Resources Corp. | CA74358Q1054
Table of contents:
Author
Fabian Lorenz
For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.
Tag cloud
Shares cloud
Prospect Ridge Resources: Another promising gold find
For Prospect Ridge Resources Corp., the acquired historical concession areas are turning more and more into real gold mines. The Canadian Company wants to bring them back to life with modern technology, and the plan seems to be working. Prospect Ridge has published positive exploration data several times in the past months. Preliminary results were recently released from the Hugin zone in the recently acquired Knauss Creek concession area. Assays have returned up to 3.49 g/t gold in slots over 0.73 meters. The entire slot averaged 2.4 g/t over 1.54 meters. The Hugin Zone is located only a few kilometers from a direct rail link to the deepwater port at Kitimat. The nearest logging road is only 1.3 km away. In early December, Knauss Creek already reported assay data of up to 57.3 g/t gold and 116 g/t silver, 7.03% lead, 0.5% copper and 2.46% zinc.
Knauss Creek is adjacent to the Holy Grail permit area. Holy Grail is the Prospect Ridge flagship located adjacent to the so-called "Golden Triangle" in western Canada. There are 12 historic mines on the 70,000-hectare property. Rocks have already been found on the property where gold can be seen with the naked eye. In addition, Holy Grail offers world-class infrastructure, including two highways, rail lines, power lines, and forest roads. In late November, exploration work revealed 117 g/t gold and 578 g/t silver. Furthermore, the property also has indications of other metals, such as copper, molybdenum and even lithium. With a market capitalization of around CAD 34 million, Prospect Ridge does not appear to be too highly valued. The share is now also traded in Germany. However, orders should only be placed with a limit. With a bit of patience, the share could become a goldmine for investors in the medium term.
BioNTech: New order from Germany soon?
After the vaccination campaign for 5 to 11 year olds, there is again positive news about BioNTech. A preliminary evaluation in South Africa has shown that the COVID-19 vaccine from the Mainz-based Company prevents "only" 33% of infections in Omicron but protects 70% against severe disease. The data refers to a double vaccination. The booster should, therefore, further improve the efficacy. The analysis was based on around 211,000 positive test results, of which about 78,000 were found to contain the Omicron variant. In addition, BioNTech should soon benefit from new orders. Health Minister Karl Lauterbach announced Wednesday that the Company's vaccine inventory was insufficient for the booster campaign. He also said that the quantities already ordered for the first quarter of 2022 were too low. Accordingly, demand for the BioNTech vaccine is likely to remain high, especially since booster vaccinations are also in full swing in the United Kingdom, where Omicron is expected to become the predominant variant as early as this week.
Plug Power enters into cooperation in the USA
The Plug Power share has recently corrected significantly. Within four weeks, the share price fell from EUR 39 to EUR 26. However, the hydrogen specialist from the United States seems to be doing well operationally. A partnership in the home market USA was recently reported. With the transport Company Certarus, Plug Power wants to expand its local delivery capacities further. Certarus is a leader in North America in the transportation of compressed natural gas. Plug Power's customers will be supplied with green hydrogen via this established logistics platform with a fleet of compressed natural gas trailers. Deliveries of up to 10 tons per day are scheduled to begin as early as the first quarter of next year. Plug Power is thus taking another step toward meeting its medium-term goals. By 2028, up to 1,000 tons of green hydrogen will be delivered to customers worldwide every day.
When the stock market environment stabilizes, positive corporate news will again come into focus. The BioNTech share will continue to be driven by the development of the Corona pandemic, even though the Company is working hard on research in the cancer area. Prospect Ridge is still largely unknown. But if positive results continue to be reported, that could change quickly. Plug Power underpins its leading position in the hydrogen sector with its cooperation with Certarus.
Conflict of interest
Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.
Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.
Risk notice
Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.
The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.
The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.
